Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells

scientific article published on 12 December 2013

Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3892/MMR.2013.1860
P698PubMed publication ID24337075
P5875ResearchGate publication ID259321938

P2093author name stringJie Fu
Xin Gao
Haifeng Song
Huahong Xie
Lihou Dong
Lun Ou
Liucun Gao
Jia Zou
Shensi Xiang
P433issue3
P921main subjecthypoxiaQ105688
metastatic potentialQ122615215
P304page(s)1032-1036
P577publication date2013-12-12
P1433published inMolecular Medicine ReportsQ26842180
P1476titleGankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells
P478volume9

Reverse relations

cites work (P2860)
Q39319386Gankyrin as a potential therapeutic target for cancer
Q37701508Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
Q38714564Gankyrin regulates cell signaling network
Q47661011Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
Q90111166POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway
Q38696589Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses
Q41893637TGF-β1 signaling pathway serves a role in HepG2 cell regulation by affecting the protein expression of PCNA, gankyrin, p115, XIAP and survivin
Q61443232The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin
Q47245509Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines
Q41615123Upregulation of PSMD10 caused by the JMJD2A histone demethylase

Search more.